Anti-inflammatory and Anti-angiogenic Effects of Bioconverted Picrasma quassioides Extract: A Comparative Study on NF-κB Signaling Pathway Inhibition and Angiogenesis Suppression

다국어 초록 (Multilingual Abstract)

Purpose: This study aimed to compare the anti-inflammatory and anti-angiogenic properties of bioconverted Picrasma quassioides extract (B-P.Q) with those of the non-bioconverted extract (P.Q) and peony root bark extract (BOT). Methods: The research utilized several experimental techniques, including cell viability assays on NIH 3T3 fibroblasts, measurement of NF-κB-related signaling protein activation, chorioallantoic membrane (CAM) assays, tube formation assays, and cell migration inhibition assays using human umbilical vein endothelial cells (HUVECs). These methods were employed to evaluate cytotoxicity, anti-inflammatory effects, and anti-angiogenic properties of the extracts. Results: B-P.Q demonstrated no cytotoxicity at the tested concentrations and significantly inhibited the activation of NF-κB-related signaling proteins (p-p38, p-Akt-1, p-SAPK/JNK, p-MEK1/2, and p-IκB) compared to P.Q and BOT. In angiogenesis experiments, B-P.Q showed superior inhibition of new blood vessel formation in CAM assays, effectively suppressed tube formation, and significantly inhibited HUVEC migration compared to controls and P.Q. Conclusion: The study found that bioconverted Picrasma quassioides extract (B-P.Q) has strong anti-inflammatory and anti-angiogenic properties, consistently outperforming non-bioconverted P.Q and BOT in various experimental models. These results suggest that B-P.Q holds significant promise as a therapeutic agent for chronic inflammatory conditions, particularly those involving excessive angiogenesis. The research underscores the effectiveness of bioconversion in enhancing the bioactive properties of natural extracts and opens up new possibilities for developing treatments for inflammatory skin problems.